Avadel Pharmaceuticals
AVDL
#4806
Rank
NZ$3.67 B
Marketcap
NZ$37.47
Share price
0.00%
Change (1 day)
187.91%
Change (1 year)

Earnings for Avadel Pharmaceuticals (AVDL)

Earnings in 2025 (TTM): -NZ$6.59 Million

According to Avadel Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.24 Billion. In 2024 the company made an earning of -NZ$84.98 Million, an increase over its 2023 earnings that were of -NZ$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Avadel Pharmaceuticals from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$6.59 Million-92.25%
2024 -NZ$84.98 Million-69.47%
2023 -NZ$0.28 Billion44.27%
2022 -NZ$0.2 Billion19.64%
2021 -NZ$0.17 Billion1732.84%
2020 -NZ$8.8 Million-86.83%
2019 -NZ$66.8 Million-65.92%
2018 -NZ$0.2 Billion-222.16%
2017 NZ$0.16 B-1053.49%
2016 -NZ$16.83 Million-112.59%
2015 NZ$0.13 B-185.94%
2014 -NZ$0.16 Billion66.04%
2013 -NZ$93.66 Million582.16%
2012 -NZ$13.73 Million-7.6%
2011 -NZ$14.86 Million-2.1%
2010 -NZ$15.18 Million32.52%
2009 -NZ$11.46 Million-64.36%
2008 -NZ$32.14 Million-52.93%
2007 -NZ$68.27 Million5.66%
2006 -NZ$64.62 Million17.86%
2005 -NZ$54.82 Million-375.09%
2004 NZ$19.92 M-406.44%
2003 -NZ$6.51 Million-145.2%
2002 NZ$14.38 M-363.36%
2001 -NZ$5.47 Million-80.62%
2000 -NZ$28.2 Million132.68%
1999 -NZ$12.12 Million-50.34%
1998 -NZ$24.4 Million54.85%
1997 -NZ$15.76 Million-28.35%
1996 -NZ$21.99 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.4 Billion 6,931.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$31.44 Million 457.62%๐Ÿ‡บ๐Ÿ‡ธ USA